Serveur d'exploration Tocilizumab - Analysis (2020)

Index « Auteurs » - entrée « Kei Nakashima »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Kei Ikeda < Kei Nakashima < Keiichi Yamamoto  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
000625 (2013) Katsutoshi Ando [Japon] ; Fumiyuki Takahashi ; Shinji Motojima ; Kei Nakashima ; Norihiro Kaneko ; Kazuei Hoshi ; Kazuhisa TakahashiPossible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia.

List of associated KwdEn.i

Nombre de
documents
Descripteur
1Aged
1Antibodies, Monoclonal, Humanized (immunology)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Cachexia (complications)
1Cachexia (diagnosis)
1Cachexia (drug therapy)
1Carcinoma, Large Cell (complications)
1Carcinoma, Large Cell (diagnosis)
1Carcinoma, Large Cell (therapy)
1Combined Modality Therapy
1Fatal Outcome
1Humans
1Lung Neoplasms (complications)
1Lung Neoplasms (diagnosis)
1Lung Neoplasms (therapy)
1Male
1Receptors, Interleukin-6 (immunology)
1Treatment Outcome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Author.i -k "Kei Nakashima" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Author.i  \
                -Sk "Kei Nakashima" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Kei Nakashima
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021